The COVID-19 Vaccine Advisory Committee of the Centers for Disease Control and Prevention will attend an emergency meeting next week to discuss higher-than-expected reports of heart inflammation in young men who received their second dose of Pfizer and Moderna vaccines.
The June 18 meeting will address conditions that are very rare and not directly related to vaccines.
As of May 31, the agency had received 275 preliminary reports of heart inflammation – known as myocarditis and pericarditis – among 16- to 24-year-olds, said Dr. Tom Shimabukuro of the CDC.
MODERN LOOKS FOR PERMISSION FOR COVID-19 VACCINE FOR TEEN
More than 1
“This is a small comparison between apples and oranges, because again these are preliminary reports. Not all of them will turn out to be real reports of myocarditis or pericarditis,” Shimabukuro said, according to CBS News.
Click here to get the FOX NEWS app
Shimabukuro said the condition is more common in younger men. Most of those who reported the condition have now fully recovered, he said.